Diabetes device makers lead the smaller medtechs

Last year investors flocked to the medtech sector, lured by the promise medical devices held for treating and diagnosing Covid. Despite the great strides that have been taken in combating the coronavirus, excitement has since dimmed, and last year medical device makers whose market cap sits beneath $10bn failed to see the enormous changes in valuation that they had enjoyed – or mourned – in 2020.